Alerts will be sent to your verified email
Verify EmailVENMAX
Venmax Drugs&Pharma
|
Link Pharma Chem
|
Emmessar Biotech&Nut
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-44.32 % | 1.59 % | 13.7 % |
5yr average Equity Multiplier
|
-0.19 | 1.99 | 1.24 |
5yr Average Asset Turnover Ratio
|
0.32 | 1.33 | 0.36 |
5yr Avg Net Profit Margin
|
-30.94 % | -0.06 % | 71.53 % |
Price to Book
|
3.42 | 1.26 | 2.08 |
P/E
|
0.0 | 0.0 | 41.06 |
5yr Avg Cash Conversion Cycle
|
0.0 | 82.44 Days | 68.18 Days |
Inventory Days
|
24.83 Days | 64.96 Days | 62.21 Days |
Days Receivable
|
0.0 | 72.97 Days | 10.88 Days |
Days Payable
|
189.56 Days | 84.21 Days | 199.95 Days |
5yr Average Interest Coverage Ratio
|
-318.36 | 2.35 | 815.2 |
5yr Avg ROCE
|
-45.33 % | 5.35 % | 19.97 % |
5yr Avg Operating Profit Margin
|
-50.41 % | 3.76 % | -101.39 % |
5 yr average Debt to Equity
|
-0.64 | 0.49 | 0.0 |
5yr CAGR Net Profit
|
n/a | n/a | 0.0 |
5yr Average Return on Assets
|
187.49 % | 0.6 % | 10.86 % |
Shareholdings
|
|||
Promoter Holding
|
23.13 % | 51.49 % | 59.53 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 1.34 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Venmax Drugs&Pharma
|
Link Pharma Chem
|
Emmessar Biotech&Nut
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|